DAVID POPLACK to Melphalan
This is a "connection" page, showing publications DAVID POPLACK has written about Melphalan.
Connection Strength
0.133
-
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer. Cancer Res. 1995 Sep 15; 55(18):4069-72.
Score: 0.107
-
Characterization of cross-resistance to methotrexate in a human breast cancer cell line selected for resistance to melphalan. Biochem Pharmacol. 1995 Apr 18; 49(8):1069-78.
Score: 0.026